Skip to main content
Cochlear Limited (ASX:COH)
Australia flag Australia · Delayed Price · Currency is AUD
269.47
-2.81 (-1.03%)
At close: Dec 5, 2025

Cochlear Revenue

In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B AUD with 4.81% growth. Cochlear had revenue of 1.17B in the half year ending June 30, 2025, with 11.46% growth.

Revenue
2.34B
Revenue Growth
+4.81%
P/S Ratio
7.52
Revenue / Employee
426.02K
Employees
5,500
Market Cap
17.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20252.34B107.50M4.81%
Jun 30, 20242.24B299.50M15.47%
Jun 30, 20231.94B287.80M17.46%
Jun 30, 20221.65B150.70M10.06%
Jun 30, 20211.50B177.00M13.40%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 23.73B
Pro Medicus 212.98M
Sonic Healthcare 9.65B
Ramsay Health Care 17.79B
Ansell 3.06B
Telix Pharmaceuticals 1.01B
Mesoblast 26.23M
Neuren Pharmaceuticals 218.86M
Revenue Rankings

Cochlear News

More News